Top Markets
Coin of the day
PharmaSGP Holding SE PharmaSGP Holding SE

PharmaSGP Holding SE

PSG
Kedudukan dalam Saham #14725
Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE... Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.
Harga Saham
$34.40
Disegerakkan terakhir: 2025-08-11
Modal Pasaran
$396.01M
Perubahan (1 hari)
1.83%
Perubahan (1 tahun)
0.00%
Negara
DE
Perdagangan PharmaSGP Holding SE (PSG)

Kategori

Pendapatan untuk PharmaSGP Holding SE (PSG)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini PharmaSGP Holding SE, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi PharmaSGP Holding SE dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa